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Abstract
Objective: To assess the role of foot dermatomycosis (ti-
nea pedis and onychomycosis) and other candidate risk
factors in the development of acute bacterial cellulitis of
the leg. Methods: A case-control study, including 243
patients (cases) with acute bacterial cellulitis of the leg
and 467 controls, 2 per case, individually matched for
gender, age (B5 years), hospital and admission date (B2
months). Results: Overall, mycology-proven foot derma-
tomycosis was a significant risk factor for acute bacterial
cellulitis (odds ratio, OR: 2.4; p ! 0.001), as were tinea
pedis interdigitalis (OR: 3.2; p ! 0.001), tinea pedis plan-
taris (OR: 1.7; p = 0.005) and onychomycosis (OR: 2.2; p !
0.001) individually. Other risk factors included: disrup-
tion of the cutaneous barrier, history of bacterial celluli-
tis, chronic venous insufficiency and leg oedema. Con-
clusions: Tinea pedis and onychomycosis were found to
be significant risk factors for acute bacterial cellulitis of
the leg that are readily amenable to treatment with effec-
tive pharmacological therapy.
Copyright © 2004 S. Karger AG, Basel
Introduction
Acute non-necrotizing bacterial cellulitis of the leg
(erysipelas) is a common infection of the skin and subcu-
taneous tissue causing significant morbidity [1–3]. Foot
dermatomycosis (tinea pedis and onychomycosis) may
constitute an important, treatable risk factor for bacterial
cellulitis of the leg [4]. Fungal infection of the skin creates
breaches in the epidermis and is believed to act as a portal
of entry for bacterial pathogens. In the absence of other
predisposing factors, clinical signs suggestive of ipsilateral
athlete’s foot (tinea pedis interdigitalis) have been ob-
served in up to 80% of patients with cellulitis of the leg
[5]. In 23% of patients with both tinea pedis and cellulitis,
the dermatophyte infection was identified as the sole pre-
disposing factor for cellulitis [6]. A case-control study of
167 patients with non-necrotizing bacterial cellulitis of
the leg identified several risk factors, including lymph-
oedema, disruption of the skin barrier (mainly skin ulcer
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and toe-web intertrigo), leg oedema, venous insufficiency
and being overweight, which were significantly associated
with bacterial cellulitis [4]. In this study, toe-web inter-
trigo was only diagnosed clinically, without mycological
examination.
Interestingly, the population-attributable risk (PAR) of
bacterial cellulitis (i.e. the percentage of cases of bacterial
cellulitis that could potentially be avoided if the risk fac-
tor was removed) was highest for toe-web intertrigo; 60%
of cellulitis cases were attributable to this factor. Toe-web
intertrigo is a highly prevalent condition, due primarily to
fungal infection of the foot (tinea pedis); it is also fre-
quently associated with concomitant mycological infec-
tion of the nail (onychomycosis) and of the plantar region
of the foot (tinea pedis plantaris) [5–7].
The objectives of the present study were to investigate
the role of mycology-proven foot dermatomycosis (tinea
pedis and onychomycosis) in the development of acute
bacterial cellulitis of the leg, and to identify other risk fac-
tors for the disease.
Methods
A multicentre, prospective case-control study was performed in
patients with bacterial cellulitis of the leg. The protocol was approved
by the appropriate institutional review boards, and all subjects gave
their written informed consent to participate. Recruitment was from
30 hospitals in Austria, France, Germany and Iceland, with a mini-
mum of 10 case patients per centre; case patients were consecutive
adults admitted to either in-patient or out-patient dermatology
departments for treatment of bacterial cellulitis of the leg (either first
episode or recurrent). Patients were enrolled as cases if they experi-
enced an acute (within 48 h) onset of signs and symptoms of bacterial
cellulitis, consisting of well-demarcated plaque-like cutaneous le-
sions, characterized by localized erythema, increased warmth and
swelling, and associated with fever 138 °C and/or chills. In all cases,
a dermatologist clinically validated the diagnosis of acute bacterial
cellulitis of the leg. Patients were not enrolled if they had bilateral
cellulitis, abscesses or necrotizing fasciitis of the leg, or if they had
used topical antifungal agents within 1 week or systemic antifungal
agents within 4 weeks before admission.
Control subjects were patients admitted to the same hospital,
with an acute condition. Two controls were enrolled per case, indi-
vidually matched for age (B5 years), gender, hospital and date of
admission (B2 months of the case patient). Exclusion criteria for
concomitant conditions and antifungal treatments were similar to
those for cases.
All data were obtained during a single visit by a dermatologist
who recorded the patient’s medical history and examined the feet for
clinical signs of dermatomycosis. The severity of signs of tinea pedis
interdigitalis (scaling, fissuring and maceration) was rated for each
toe-web on both feet, and signs of tinea pedis plantaris (scaling, fis-
suring and blistering) were evaluated on the soles of both feet. Each
disease sign was rated on a 4-point scale (0 = none, 1 = mild, 2 =
moderate, 3 = severe). Toenails from all toes, with the exception of
the fifth (smallest) toe, were assessed on both feet for the presence or
absence of clinical signs suggestive of onychomycosis.
Clinically significant signs of foot dermatomycosis were deter-
mined from clinical examination of the target leg. Clinically signifi-
cant suspicion of tinea pedis interdigitalis was defined as at least 1
toe-web on the target leg with a score of at least 2 for scaling and/or
fissuring (maceration was not included as it is non-specific). Clinical-
ly significant suspicion of tinea pedis plantaris was defined as a plan-
tar region on the target leg with a score of at least 2 for clinical signs,
i.e. scaling, fissuring and blistering. Clinically significant suspicion of
onychomycosis was defined as the presence of nail abnormalities sug-
gestive of onychomycosis on at least one toenail on the target leg.
Mycological samples were obtained from the foot of the affected
leg in cases, and the corresponding foot in controls. Two samples
were taken from each of the three sites: interdigital, plantar and nail.
If signs of dermatomycosis were present, samples were taken from
the most severely affected site; otherwise, samples were obtained
from the third and fourth interdigital spaces, 2 different locations on
the plantar region and from 2 toenails (including the big toe). Sam-
ples were sent to a central laboratory and evaluated by personnel
unaware of their origin. Specimens were examined using KOH wet
mounts for the presence of hyphae and were cultured in Sabouraud
dextrose agar. The inoculated plates were incubated at a temperature
of 28°C and assessed for the first time after 2 weeks. Cultures were
confirmed negative following re-examination after a further 4 weeks.
Patients with a positive result were referred to their general practi-
tioner for treatment.
Characterization of Other Potential Risk Factors
Other risk factors such as being overweight (defined as body mass
index 627) [8], alcohol/smoking history and previous medical condi-
tions as reported by the patient were also recorded. Patients were
examined for the presence of potential risk factors such as venous
insufficiency, leg ulcer and abolition of peripheral pulse or leg
oedema.
Statistical Analysis
All demographic and background characteristics were based on
the ‘all subjects population’ defined as all subjects (cases and con-
trols) from whom data were available and who had signed the
informed consent.
The analysis population included ‘set subjects’ defined as all sub-
jects (cases and controls) from whom data were available, who had
signed the informed consent and who were part of a set of 1 case and
at least 1 control.
The primary evaluation was performed according to a 2-step hier-
archical testing procedure, firstly to demonstrate an association
between dermatomycosis on the target leg and bacterial cellulitis and,
secondly, between tinea pedis interdigitalis and bacterial cellulitis.
The second test was only analysed if the first test showed significance
[limits of 95% confidence interval (CI) of odds ratio (OR) not includ-
ing 1]. The OR was estimated using standard methods of analysis of
matched data [9]. All ORs were presented together with the 95%,
two-sided CIs. For this primary analysis, only the results of mycologi-
cal culture were taken into account as this was considered proof of a
diagnosis of foot mycosis. However, OR for positive mycology as
defined by positive direct microscopy and/or positive mycological
culture was also determined.
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Fig. 1. Prevalence of foot dermatomycosis,
as defined by positive mycology (positive
culture and/or microscopy).
The secondary evaluation examined the association between bac-
terial cellulitis and subtypes of dermatomycosis using the same meth-
odology as above. For this evaluation, the mycology results were taken
into account. Additionally, a multivariate model was set up to further
investigate the possible influence of other risk factors. Conditional
logistic regression was applied to this analysis using a forward-step
selection method. Possible covariates were chosen from previous uni-
variate analyses with p ! 0.1. Individual score tests were used to select
risk factors for the model. At each step, risk factors were added to the
model in order of significance (the variable with the largest ¯2 value
was added to the model). The step was repeated, adjusting for vari-
ables already in the model, until all significant variables were
included. A factor was considered significant if p ^ 0.05 at that step.
The PAR estimates the proportion of disease cases that could be
prevented if risk factors were reduced or eliminated. The PAR was
calculated for dermatomycosis, tinea pedis plantaris and onychomy-
cosis, as well as for each of the significant risk factors determined
from the multivariate analysis. The control group was assumed to be
representative of the general population, so the prevalence of each
risk factor in the general population was derived from its prevalence
in the control.
The PAR was therefore calculated as:
PAR% = 
P(RR – 1)
P(RR – 1) + 1
!100
where PAR is the population-attributable risk, P is the prevalence of
the factor in the control group and RR is the relative risk.
The required sample size was calculated from an estimated over-
all prevalence of 620% for dermatomycosis and 615% for tinea
pedis interdigitalis, a common OR of 2, a correlation of exposure
between a case and 1 control patient of 0.2 and a two-sided 5% signif-
icance level. The overall statistical power of the hierarchical testing
procedure was at least 82%. The sample size calculation was per-
formed using PASS© 6.0 software (NCSS Statistical Software, Kays-
ville, Utah, USA; matched case-control module). No adjustments for
drop-outs were required as this was a ‘one-visit’ study.
Results
The total population (all subjects) on which demo-
graphic and background characteristics were based con-
sisted of 243 cases and 467 controls. The set subject popu-
lation (with at least 1 matched control for each case) on
which all the analysis was performed included 228 cases
and 439 controls.
Mean ages in cases and controls were 59 and 61 years,
respectively, and the male-to-female ratio was approxi-
mately 50:50. Cases and controls were similar demo-
graphically and with regard to most other baseline fac-
tors.
Mycology-Proven Foot Dermatomycosis among Cases
and Controls
The prevalence of any foot dermatomycosis, tinea
pedis interdigitalis, tinea pedis plantaris or onychomyco-
sis defined by positive mycology, i.e. positive culture or
positive direct microscopic examination, was consider-
ably higher in cases (56.1, 39.8, 33.0 and 32.2%, respec-
tively) than in controls (36.4, 21.2, 22.8 and 18.4%,
respectively; fig. 1). The same imbalance was apparent if
the analyses were restricted to positive cultures for derma-
tophytes, yeasts or moulds. Culture-positive foot derma-
tomycosis and tinea pedis interdigitalis were found in
42.5 and 29.8% of cases compared with 24.1 and 13.3% of
controls, respectively.
As expected, the majority of cultures (67%) was posi-
tive for a dermatophyte. Yeasts were the second most
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Fig. 2. Fungal infections in patients with bacterial cellulitis of the leg
and foot dermatomycosis. Single infection: onychomycosis or tinea
pedis plantaris or tinea pedis interdigitalis alone; double infection:
onychomycosis and tinea pedis plantaris or tinea pedis interdigitalis,
or tinea pedis plantaris and tinea pedis interdigitalis; triple infection:
onychomycosis, tinea pedis plantaris and tinea pedis interdigitalis.
Fig. 3. Prevalence of clinically significant signs suggestive of derma-
tomycosis.
Table 1. Univariate OR of foot dermatomycosis, defined by positive
mycology, in cases and controls
Univariate OR 95% CI
Any dermatomycosis 2.4** 1.7–3.3
Tinea pedis interdigitalis 2.8** 1.9–4.2
Tinea pedis plantaris 1.7* 1.2–2.4
Onychomycosis 2.2** 1.5–3.3
* p = 0.005; ** p ! 0.001.
prevalent organism. Amongst dermatophytes, Trichophy-
ton dermatophytes (T. rubrum and T. mentagrophytes)
were the most prevalent organisms cultured from all the
sites sampled in both groups.
Culture-proven dermatomycosis was shown to be a sig-
nificant risk factor for bacterial cellulitis (OR: 2.4, 95%
CI: 1.7–3.5, p ! 0.001); this was also shown for tinea pedis
interdigitalis (OR: 3.2, 95% CI: 2.0–5.0, p ! 0.001). The
magnitude of the risk (OR) was similar when evaluated by
positive mycology (defined as positive culture and/or
microscopy; table 1). Mycology-proven tinea pedis plan-
taris and onychomycosis were also identified as signifi-
cant risk factors for bacterial cellulitis (table 1).
Among patients with bacterial cellulitis and foot der-
matomycosis, as determined by positive mycology, 82%
had fungal infections at several sites (fig. 2). Almost half
(47%) of these patients had a triple infection and more
than one third had a double infection, indicating that
most patients had widespread foot mycosis.
Severity of Signs of Dermatomycosis
Tinea pedis interdigitalis. Patients with bacterial cellu-
litis had a significantly higher mean number of affected
interdigital spaces than controls (2.6 and 1.4, respectively;
p ! 0.001) and had significantly higher scores for scaling
(cases: mean = 3.6; controls: mean = 1.7), maceration
(cases: mean = 1.8; controls: mean = 0.7), fissuring (cases:
mean = 1.7; controls: mean = 0.5) and total disease severi-
ty (cases: mean = 7.1; controls: mean = 2.9), compared
with controls (p ! 0.001).
Tinea pedis plantaris. The signs of tinea pedis plantaris
(scaling, fissuring and blistering) were severer in cases,
compared with controls. The difference in terms of signs
and symptoms displayed on the target leg between groups
(cases: mean = 0.9, median = 1.0; controls: mean = 0.4)
was statistically significant (p ! 0.001).
Onychomycosis. In patients with onychomycosis, the
mean number of toenails affected on the target leg was
greater in cases (mean = 1.7 toenails affected) compared
with controls (mean = 0.9; p ! 0.001).
Clinically Significant Signs of Dermatomycosis
The prevalence of clinically significant signs of tinea
pedis interdigitalis, tinea pedis plantaris and onychomy-
cosis was higher in cases than controls (fig. 3).
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Table 2. Non-mycological risk factors
OR 95% CI Prevalence, %
cases
(n = 243)
controls
(n = 467)
History of bacterial cellulitis 29 11.7–72 34.0 1.0
Disruption of cutaneous barrier 18.2 9.2–36.2 39.0 4.5
Ulcer on the target leg 9 3.7–21.8 12.0 1.5
Chronic leg oedema 8.5 4.3–16.9 21.0 4.0
History of deep venous thrombosis 5.6 2.5–12.6 10.0 3.0
Varicose eczema 4.6 1.4–14.7 4.5 1.5
Abolition of peripheral pulse 2.9 1.3–6.1 9.0 3.0
Hyperpigmentation 2.9 1.8–4.5 25.5 12.0
Being overweight 2.85 2.0–4.0 62.6 37.2
History of venous insufficiency 2.8 1.9–4.1 49.0 27.0
History of varicose veins 2.2 1.5–3.3 40.0 24.0
History of venous leg surgery 1.8 1.05–3.2 12.0 7.0
Table 3. Multivariate risk factors for
bacterial cellulitis of the leg Adjusted OR Prevalence
in controls, %1
PAR
%
Disruption of the cutaneous barrier 22.0 (9.4–51.5) 4.5 48.5
Being overweight 2.8 (1.6–5.0) 37.2 40.7
Tinea pedis interdigitalis2 3.2 (1.6–6.3) 13.3 22.5
History of bacterial cellulitis 24.0 (7.1–81.2) 1.1 20.2
Chronic leg oedema 4.5 (1.3–15.6) 4.3 13.2
Figures in parentheses indicate 95% CI.
1 An estimate of prevalence in the population.
2 Positive culture only.
Additional Univariate Risk Factors
In the univariate analysis, additional significant risk
factors for bacterial cellulitis were: history of bacterial cel-
lulitis of the target leg, disruption of the cutaneous barrier
and being overweight (table 2). The most frequent causes
of disruption of the cutaneous barrier other than foot der-
matomycosis and venous leg ulcers were wounds and
pressure ulcers. Smoking (27.1% of controls and 22.4% of
cases), alcohol consumption (5.5% of controls and 5.7%
of cases), a history of atherosclerosis on the target leg
(3.0% of controls and 4.8% of cases) or diabetes (12.5% of
controls and 13.2% of cases) were not identified as signifi-
cant risk factors.
Conditional Logistic Regression Analysis
Significant (p ! 0.1) univariate risk factors incorpo-
rated in the multivariate model were: foot dermatomyco-
sis, i.e. tinea pedis interdigitalis, onychomycosis, tinea
pedis plantaris (all defined by positive mycology); being
overweight; history of bacterial cellulitis; history of ve-
nous insufficiency; varicose veins; deep vein thrombosis;
venous leg surgery; leg ulcer; venous insufficiency; hyper-
pigmentation; disruption of the cutaneous barrier
(wound, pressure ulcer); abolition of peripheral pulse and
chronic leg oedema.
Risk factors that remained independently associated
with bacterial cellulitis in the multivariate analysis are
listed in table 3. Tinea pedis interdigitalis was amongst the
5 variables that remained independently associated with
bacterial cellulitis. Other factors with the most influence on
risk of bacterial cellulitis were: signs and symptoms of dis-
ruption of the cutaneous barrier on the target leg; history of
bacterial cellulitis on the target leg; chronic leg oedema of
the target leg, and being overweight.
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The PAR was estimated for each risk factor that
remained significant in the multivariate analysis (table 3).
Interestingly, 2 preventable risk factors, i.e. overweight
and tinea pedis interdigitalis, were associated with 40.7
and 22.5% of the cases of acute bacterial cellulitis of the
leg, respectively.
Discussion
This study demonstrated a significant association be-
tween dermatomycosis of the foot and acute bacterial cel-
lulitis of the leg. The prevalence of mycology-proven foot
dermatomycosis was higher in patients with bacterial cel-
lulitis than in controls, with the majority of patients hav-
ing fungal infections at several sites. Both the extent and
severity of signs of dermatomycosis were more pro-
nounced in cases, compared with controls. The different
types of dermatomycosis (i.e. tinea pedis interdigitalis,
tinea pedis plantaris and onychomycosis) were each, sepa-
rately, found to be significant risk factors for bacterial cel-
lulitis. Since mycological samples were obtained during
the course of acute cellulitis and since there is no pub-
lished evidence that systemic antibiotics are associated
with other mycoses than gastrointestinal tract candidiasis
and napkin dermatitis, there is no reason to suspect that
dermatomycosis was a complication of antibiotic therapy.
Additional risk factors for acute bacterial cellulitis were:
disruption of the cutaneous barrier, being overweight,
signs of venous insufficiency and chronic leg oedema.
Similar to the results of the study of Dupuy et al. [4],
this study did not identify diabetes as a risk factor, which
appears to contradict current clinical experience [10].
However, it can be hypothesized from this study and the
study by Dupuy et al. [4] that most cases of cellulitis in
diabetic patients could not be included. Indeed, bacterial
cellulitis in diabetic patients usually manifests as a sub-
acute infection, often with abscess or drainage, and there-
fore did not meet the diagnostic criteria of acute bacterial
cellulitis (erysipelas) without abscess required for inclu-
sion in the present study.
The results presented here are consistent with the
study by Dupuy et al. [4] but the present study has several
strengths. A larger sample size was included in this study
(n = 710) compared to Dupuy et al. (n = 461). However,
the most notable difference is the absence of a laboratory
diagnosis in the study of Dupuy et al. [4]. In this study,
both microscopy and culture analyses were undertaken to
confirm the presence of foot dermatomycosis.
Both studies identified disruption of the cutaneous
skin barrier, leg oedema, venous insufficiency and being
overweight as significant risk factors associated with bac-
terial cellulitis of the leg. The PAR for toe-web intertrigo
was higher in the study by Dupuy et al. [4], compared to
culture-proven tinea pedis in the present study (60 vs.
22.5%, respectively). The lower sensitivity of the micro-
biological methods used for assessing tinea pedis interdi-
gitalis may account at least in part for this discrepancy. It
has been estimated that 30–50% of patients with derma-
tomycosis fail to show positive mycology [7, 11]. If the
sensitivity of mycological culture in the present study is
assumed to be only 60% in both cases and controls, the
true prevalence of culture-proven tinea pedis interdigital-
is in controls would be 22%, which would translate into a
PAR of 33% for tinea pedis interdigitalis.
PAR was high for overweight patients and those with a
history of bacterial cellulitis. The PAR was highest for dis-
ruption of the cutaneous barrier, thus emphasizing that
the presence of a portal of entry for bacteria is a predispos-
ing factor for bacterial cellulitis.
Amongst risk factors identified in the multivariate
analysis, tinea pedis interdigitalis is the most amenable to
therapeutic intervention. Although foot dermatomycosis
is highly prevalent, only a minority of patients with der-
matomycosis is treated [12, 13]. The disease may be
asymptomatic, and patients who do not experience com-
plications may not seek medical advice. Furthermore, the
medical complications associated with foot dermatomy-
cosis may be underestimated. This study highlights the
importance of diagnosing and treating foot dermatomyco-
sis, since it is an easily treatable risk factor for bacterial
cellulitis. Given the fact that most patients suffer from
infection at multiple sites including interdigital spaces,
plantar region and nail, careful sampling and specialized
care are appropriate for treatment selection and follow-
up.
Conclusion
Results from this study demonstrate that foot dermato-
mycoses (i.e. tinea pedis and onychomycosis) are signifi-
cant risk factors for bacterial cellulitis of the leg. As these
represent risk factors that are the most amenable to treat-
ment, careful screening and treatment of foot dermatomy-
coses can help eliminate these specific risk factors for bac-
terial cellulitis of the leg, especially in patients with other
risk factors, such as history of this disease, chronic venous
insufficiency and being overweight.
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